Concepedia

Abdulrahman Hamasy

AH

Statistics

Publications

4

Citations

120

H-Index

4

Active since

2013

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

Science for Life Laboratory

Abdulrahman Hamasy is an author at Karolinska Institutet specializing in drug discovery, chemistry, and molecular pharmacology.

Top concepts

Publications per year

2013–2018

4

Publications

4

Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant

Abdulrahman Hamasy, Q. Wang, K. Emelie M. Blomberg et al. · Leukemia · 2016 · 56 citations · Full text

, , +17

Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 ( PGM3 ) gene

Karin E. Lundin, Abdulrahman Hamasy, Paul Hoff Backe et al. · Clinical Immunology · 2015 · 34 citations · Full text

Signaling of the ITK (Interleukin 2-inducible T Cell Kinase)-SYK (Spleen Tyrosine Kinase) Fusion Kinase Is Dependent on Adapter SLP-76 and on the Adapter Function of the Kinases SYK and ZAP70

Alamdar Hussain, Manuela O. Gustafsson, Merve Uslu et al. · Journal of Biological Chemistry · 2013 · 18 citations · Full text

Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report

Karin E. Lundin, Qing Wang, Abdulrahman Hamasy et al. · BMC Pediatrics · 2018 · 12 citations · Full text

Rows per page

1–4 of 4